How much does the chief earn – CEO pay at CROs fiscal 2011

By Nick Taylor

- Last updated on GMT

How much does the chief earn – CEO pay at CROs fiscal 2011
Outsourcing-Pharma looks at the wages of the remaining big four public CROs and how they compare to operating income.

After their full-year results the big four public CROs (contract research organisations) – Charles River Laboratories, Covance, Icon, and Parexel – posted the earnings of their CEOs in regulatory filings.

Joe Herring, CEO of Covance, was the big winner, with an uptick in salary helping his total earnings to increase by one-fifth to $7.2m (€5.4m). An uptick in earnings by James Foster, CEO of Charles River, brought the total up to $5.5m and overturned the 2010 fall, when the CRO posted an operating loss.

Herring and Foster both run CROs with preclinical assets and earn notably more than their peers at Icon and Parexel. Josef von Rickenbach, CEO of Parexel, earned a total of $3.8m in the CRO’s fiscal 2011, which ended in June.

Peter Gray, the former CEO of Icon, earned the least, $1.7m, but his CRO also trails the others in net sales. Gray stepped down as CEO of Icon in September but his earnings are used for the purpose of the visualisation. 

All data is taken from the CROs’ filings with the US Securities and Exchange Commission​. 

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars